A new chapter in Polpharma history opened on 20 July. The company became a privately owned entity, with all its shares held by Polish investors. The Spectra Management and Prokom Investments Consortium became the majority shareholder of the Company. This was the beginning of restructuring and significant investment in the development of the company.